Adults with untreated metastatic adenocarcinoma of the pancreas were randomised ( @:@ ) to receive intravenous gemcitabine @ mg/m ( @ ) ( weekly @ for @ weeks , then days @ , @ and @ of @-day cycles ) plus trametinib or placebo @mg daily .